Skip Navigation
Skip Website Tools

Contact Info

Rebecca Prevots, Ph.D., M.P.H.
Building 15B-1, Room 100
8 West Drive
Bethesda, MD 20892-0485
Phone: 301-451-3058
rprevots@niaid.nih.gov

Laboratory of Clinical Infectious Diseases

Skip Content Marketing
  • Share this:
  • submit to facebook
  • Tweet it
  • submit to reddit
  • submit to StumbleUpon
  • submit to Google +

D. Rebecca Prevots, Ph.D., M.P.H.

Chief, Epidemiology Unit, LCID

Major Areas of Research

  • Epidemiology of nontuberculous mycobacteria (NTM) and bronchiectasis in the United States and globally
  • Spatio-temporal mapping and ecology of infectious diseases
  • Epidemiology of severe malaria in Tanzania
 

Program Description

Epidemiology is a core science in public health that includes surveillance, observation, hypothesis testing, analytic research, and experiments and interventions. As the fundamental science of preventive medicine and public health, epidemiology has traditionally focused on disease causation through population studies. Epidemiologists develop and evaluate hypotheses about the effects of hereditary, behavioral, environmental, and healthcare factors on human health and develop the knowledge bases for disease prevention and control programs. The field is interdisciplinary and has a methodology distinct from, but dependent on, biostatistics. Epidemiologists incorporate into their research the knowledge base and tools of other disciplines including the biologic sciences, clinical research, and other population sciences.

The Epidemiology Unit leads and supports research of relevance to the mission of NIAID and the Laboratory of Clinical Infectious Diseases, with approaches that include the following:

  • Analysis of national morbidity and mortality datasets (e.g., hospital discharge datasets) to develop and test hypotheses regarding disease prevalence, trends, and risk factors
  • Integrated analysis of clinical and microbiologic data using multivariate methods to identify relative host and pathogen contributions to infection and disease
  • Design of clinical and population-based studies with appropriate methods and sampling strategies
  • Application of population-based strategies to studies of infectious disease, incorporating the tools of molecular biology and genetics into population-based samples to identify markers of disease susceptibility

Other research areas include spatio-temporal analysis of infectious diseases, pre- and post-licensure vaccine evaluation, health disparities in severe outcomes of infectious diseases, defining optimal clinical end-points for clinical trials of vaccines, and technical evaluation of data underlying science-to-policy issues.

Training is vital to the mission of the Epidemiology Unit, and we maintain ties to schools of public health in the Washington, DC, and Maryland areas, as well as around the country. We provide research training opportunities to post-baccalaureate, post-doctoral, M.P.H., and Ph.D. students. In addition, we maintain ties with academic institutions, national organizations (e.g., the Centers for Disease Control and Prevention and the Food and Drug Administration), and international organizations (e.g., World Health Organization, Pan American Health Organization) to embed trainees within ongoing research in a public health context.

back to top

Biography

Dr. Prevots began her public health research career at the New York City Department of Health in 1985, working as a public health advisor  in the AIDS surveillance and epidemiology unit. From there she went to the University of Michigan, where she earned her M.P.H. in 1988 and her Ph.D. in epidemiology in 1991. Upon completing her Ph.D., she joined the Epidemic Intelligence Service at the Centers for Disease Control and Prevention (CDC). During her time at CDC, she worked primarily on the epidemiology of vaccine preventable diseases, as well as HIV/AIDS. After joining NIAID in 2003, she began focusing on studies related to the epidemiology of tuberculosis and nontuberculous mycobacteria. In 2007, she became chief of the newly created epidemiology section in LCID and is working primarily on studies of nontuberculous mycobacteria but is also involved on a range of studies related to other infectious diseases. 

Research Group

D. Rebecca Prevots, Ph.D., M.P.H., Epidemiologist
Kenneth N. Olivier, M.D., M.P.H., Clinical Epidemiologist
Amy E. Seitz, M.P.H., Research Assistant
Jennifer Adjemian, Ph.D., Epidemiologist
Alison Binder, Postbaccalaureate IRTA

Selected Publications

Seitz AE, Prevots DR, Holland SM. Hospitalizations associated with disseminated coccidioidomycosis, Arizona and California, USA. Emerg Infect Dis. 2012 Sep;18(9):1476-9.

Adjemian J, Olivier KN, Seitz AE, Falkinham JO 3rd, Holland SM, Prevots DR. Spatial clusters of nontuberculous mycobacterial lung disease in the United States. Am J Respir Crit Care Med. 2012 Sep 15;186(6):553-8.

de Filippis I, de Lemos AP, Hostetler JB, Wollenberg K, Sacchi CT, Dunning Hotopp JC, Harrison LH, Bash MC, Prevots DR. Molecular epidemiology of Neisseria meningitidis serogroup B in Brazil. PLoS One. 2012;7(3):e33016.

Seitz AE, Olivier KN, Adjemian J, Holland SM, Prevots DR. Trends in bronchiectasis among Medicare beneficiaries in the United States, 2000-2007. Chest. 2012 Feb 2. Epub ahead of print.

Prevots DR,  Shaw PA, Strickland DS, Jackson LA, Raebel MA, Blosky MA, Montes de Oca R, Shea YR, Seitz AE, Holland SM, Olivier KN.  Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems. Am J Resp Crit Care Med. 2010 Oct 1;182(7):970-6. 

Jeon CY, Hwang SH, Min JH, Prevots DR, Goldfeder LC, Lee H, Eum SY, Jeon DS, Kang HS, Kim JH, Kim BJ, Kim DY, Holland SM, Park SK, Cho SN, Barry CE 3rd, Via LE. Extensively drug-resistant tuberculosis in South Korea: risk factors and treatment outcomes among patients at a tertiary referral hospitalClin Infect Dis. 2008 Jan 1; 46(1):42-9.

Visit PubMed for a complete publication listing.

 

Last Updated September 19, 2012